Electrical Stimulation to Improve Recovery After Peripheral Nerve Injury
NCT ID: NCT03996525
Last Updated: 2023-02-13
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
NA
7 participants
INTERVENTIONAL
2019-09-16
2022-10-03
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
This study of ES in these patients will investigate:
i) nerve regeneration over long distances;
ii) direct evidence of changes in nerve regeneration with nerve samples from the second procedure; and
iii) changes in functional outcomes in a patient population with much less variability.
Our study will provide evidence about the effect of ES in improving outcomes in patients with nerve injuries.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Functional Electrical Stimulation for Facial Muscles
NCT04457492
Electrical Stimulation to Promote Recovery in Bells Palsy
NCT03836989
Promoting Healing of Injured Nerves With Electrical Stimulation Therapy
NCT05884125
Electrical Stimulation to Enhance Peripheral Nerve Regeneration
NCT02403661
Mirror Therapy Combined With Contralaterally Controlled Functional Electrical Stimulation for Peripheral Nerve Injury
NCT06209632
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Electrical Stimulation
Electrical Stimulation
The patient will receive active electrical stimulation.
Electrical Stimulation
Two-Stage Facial Reanimation (Standard Practice) with electrical stimulation for one hour at 20Hz (Experimental Procedure).
1. Cross-Facial Nerve Graft (CFNG) immediately followed by electrical nerve stimulation proximal to the coaptation site on the donor facial nerve.
2. Nine-to-Twelve Months later, Free Muscle Transfer (FMT) followed by electrical nerve stimulation proximal to the coaptation site in the intraoral incision.
Sham Treatment
No Electrical Stimulation
The patient will receive sham electrical stimulation.
Sham Treatment
Two-Stage Facial Reanimation (Standard Practice) with sham electrical stimulation for one hour (Placebo).
1. Cross-Facial Nerve Graft (CFNG) followed by placement of unelectrified electrodes proximal to the coaptation site on the donor facial nerve.
2. Free Muscle Transfer (FMT) followed by placement of unelectrified electrodes proximal to the coaptation site in the intraoral incision.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Electrical Stimulation
Two-Stage Facial Reanimation (Standard Practice) with electrical stimulation for one hour at 20Hz (Experimental Procedure).
1. Cross-Facial Nerve Graft (CFNG) immediately followed by electrical nerve stimulation proximal to the coaptation site on the donor facial nerve.
2. Nine-to-Twelve Months later, Free Muscle Transfer (FMT) followed by electrical nerve stimulation proximal to the coaptation site in the intraoral incision.
Sham Treatment
Two-Stage Facial Reanimation (Standard Practice) with sham electrical stimulation for one hour (Placebo).
1. Cross-Facial Nerve Graft (CFNG) followed by placement of unelectrified electrodes proximal to the coaptation site on the donor facial nerve.
2. Free Muscle Transfer (FMT) followed by placement of unelectrified electrodes proximal to the coaptation site in the intraoral incision.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* i) isolated unilateral facial nerve palsy and
* ii) a functioning contralateral facial nerve.
Exclusion Criteria
* Patients with severe cognitive impairment, which would limit their participation
6 Years
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
The Physicians' Services Incorporated Foundation
OTHER
The Hospital for Sick Children
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Gregory Borschel, MD
Principal Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Kristen Davidge, MD
Role: PRINCIPAL_INVESTIGATOR
The Hospital for Sick Children
Ronald Zuker, MD
Role: PRINCIPAL_INVESTIGATOR
The Hospital for Sick Children
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
The Hospital for Sick Children
Toronto, Ontario, Canada
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
1000063546
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.